Early positive clinical results from implantation with Zimmer MotionLoc Screws

NewsGuard 100/100 Score

Zimmer Holdings, Inc. (NYSE: ZMH; SIX: ZMH), a global leader in musculoskeletal care, today announced that early clinical results of the first patients treated with Zimmer MotionLoc™ Screws were free of complications.  The Zimmer MotionLoc Screw is Zimmer Trauma's latest advancement in locking plate technology and is intended for use in conjunction with the Zimmer NCB® Polyaxial Locking Plate System.  

The Zimmer MotionLoc Screw for the NCB Polyaxial Locking Plate System offers a new option to surgeons who treat complex long bone fractures, such as those of the femur, tibia or humerus.  This technology enables the surgeon to reduce the stiffness of the locking plate construct while still maintaining the strength needed until the fracture begins to heal.  Zimmer MotionLoc technology is based on the concept of Far Cortical Locking, which may reduce the stiffness of locked plating constructs while still retaining the construct's strength.

"This new technology builds on Zimmer's longstanding tradition of offering surgeons easy-to-use products in trauma care," said Jeff Paulsen, Group President, Zimmer Global Businesses.  "We believe this screw will prove to be a game-changer for surgeons treating complex long bone fractures, without drastically altering their surgical procedure."

A total of ten patients were treated using the Zimmer MotionLoc Screws between October 2010 and January 2011, and postoperatively, surgeons reported no complications in implant application, implant fixation or fracture healing.  Specifically, surgeons commented that insertion and removal of the Zimmer MotionLoc Screws felt normal and the procedures did not require additional effort compared to standard screw insertion.

Zimmer MotionLoc Screws provide fixation in the far cortex of the diaphysis (shaft) of the bone and are locked into the plate.  Without being rigidly fixed in the near cortex, these screws flex within a controlled motion envelope.  

SOURCE Zimmer Holdings, Inc.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Rice scientists identify promising new immunological pathway to treat breast cancer bone metastases